Personalized Medicine Market Report 2007

This report presents the latest industry analysis of the emerging field of Personalized Medicine. There is increasing interest in this field driven by the development of a number of molecular diagnostics-based tests that determine a patient’s genetic predisposition to a given disease—such as cancer, or to adverse drug reactions (ADRs).

Personalized Medicine is growing rapidly—this report documents the various tests currently available, their market opportunity and hurdles to their market adoption. In addition, Select Biosciences presents in this report the current pipeline of personalized medicine-based tests in various different therapeutic areas.

This report is the only report on the marketplace that presents a market analysis of the personalized medicine space based upon a proprietary market survey performed recently by Select Biosciences. The market analysis addresses qualitative market trends and quantitative market metrics, and pinpoints the opportunities and hurdles in this market.

Topics Covered in this Report

The Personalized Medicine Space

Market Drivers

CYP450 Polymorphisms and Drug Metabolism

Personalized Medicine-based Tests on the Market Today

Pipeline of Personalized Medicine-based Tests

Regulatory Guidelines in the Personalized Medicine Space

The Molecular Diagnostics Marketplace: Quantitative Metrics, Emerging Applications, and Market Trends—Personalized Medicine is a Fast-Growing Segment of Molecular Diagnostics

Personalized Medicine Market Analysis: Qualitative and Quantitative Market Metrics based on Market Survey Data

Company Profiles: Of the Relevant Market Participants

Companies Profiled in this ReportAbbott Molecular/Vysis

Affymetrix

Agendia

Celera Diagnostics

Cepheid

Clinical Data: PGxHealth and Cogenics

Dakocytomation

decode Genetics

DNA Direct

DxS Ltd

Exact Sciences

Exagen Diagnostics

Gen-Probe

Genelex

Gene Logic

Genentech

Genomic Health, Inc.

Genzyme Genetics

Illumina

Luminex/Tm Biosciences

Monogram Biosciences

Myriad Genetics

Nanogen

Osmetech plc

Perlegen Sciences

PGxI Laboratories

Prometheus Laboratories

Roche Diagnostics

Siemens Medical Solutions Diagnostics

Target Discovery

Third Wave Technologies

XDx

Ventana Medical Systems

Published: April 2007

Pages: 104

PDF Format
Table of Contents

Price
Single User Print Version $3538.00
Electronic Site License (pdf + one print copy) $4175.00